3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Structural Insight into BLM Recognition by TopBP1

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          SUMMARY

          Topoisomerase IIβ binding protein 1 (TopBP1) is a critical protein-protein interaction hub in DNA replication checkpoint control. It was proposed that TopBP1 BRCT5 interacts with Bloom syndrome helicase (BLM) to regulate genome stability through either phospho-Ser304 or phospho-Ser338 of BLM. Here we show that TopBP1 BRCT5 specifically interacts with the BLM region surrounding pSer304, not pSer338. Our crystal structure of TopBP1 BRCT4/5 bound to BLM reveals recognition of pSer304 by a conserved pSer-binding pocket, and interactions between a FVPP motif N-terminal to pSer304 and a hydrophobic groove on BRCT5. This interaction utilizes the same surface of BRCT5 that recognizes the DNA damage mediator, MDC1, however the binding orientations of MDC1 and BLM are reversed. While the MDC1 interactions are largely electrostatic, the interaction with BLM has higher affinity and relies on a mix of electrostatics and hydrophobicity. We suggest similar evolutionarily conserved interactions may govern interactions between TopBP1 and 53BP1.

          eTOC BLURB

          TopBP1 is a hub for DNA damage signaling interactions. Sun et al. determine the structure of TopBP1 BRCT5 bound to its phosphorylated partner, Bloom syndrome helicase (BLM). The structure reveals a strikingly different binding mode than that observed for another TopBP1 BRCT5 interaction partner, MDC1.

          Related collections

          Author and article information

          Journal
          101087697
          22305
          Structure
          Structure
          Structure (London, England : 1993)
          0969-2126
          1878-4186
          8 July 2018
          14 September 2017
          03 October 2017
          13 July 2018
          : 25
          : 10
          : 1582-1588.e3
          Affiliations
          [1 ]Department of Biochemistry, University of Alberta, Edmonton, Alberta, T6G 2H7, Canada
          [2 ]Department of Oncology, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, UK
          [3 ]Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford OX3 7DQ, UK
          Author notes
          [* ]Corresponding Author and Lead Contact: mark.glover@ 123456ualberta.ca , telephone: (780) 492-2136, fax: (780) 492-0886

          AUTHOR CONTRIBUTIONS

          L.S. and Y.H. produced all proteins, performed crystallographic analysis, and performed all fluorescence polarization measurements. R.A.E. assisted with crystallographic structure determination and refinement and S.Y. assisted with λ phosphatase experiments. L.S., A.N.B., W.N., and J.N.M.G. conceived the experiments and prepared the manuscript.

          Article
          PMC6044410 PMC6044410 6044410 nihpa979864
          10.1016/j.str.2017.08.005
          6044410
          28919440
          768dd48f-059b-428e-9cef-5678af0d43e2
          History
          Categories
          Article

          phospho-peptide interactions,X-ray crystallography,fluorescence polarization,TopBP1,BLM,Bloom syndrome,BRCT

          Comments

          Comment on this article